LGALS3 and metabolic dysfunction-associated steatohepatitis: The role of Gal3 in liver fibrosis has been supported by the fact that Gal3 null mice were either resistant to the development of NASH and fibrosis [151], or attenuated inflammation and IL33-dependent fibrosis [152].